|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 3 of 13 found articles
| Title: |
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial |
| Author: |
Orkin, Chloe Molina, Jean-Michel Negredo, Eugenia Arribas, José R Gathe, Joseph Eron, Joseph J Van Landuyt, Erika Lathouwers, Erkki Hufkens, Veerle Petrovic, Romana Vanveggel, Simon Opsomer, Magda |
| Appeared in: |
The Lancet. HIV |
| Paging: | Volume 5 (2018) nr. 1 pages e23-e34 |
| Year: |
2018 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 3 of 13 found articles
| << previous | next >> |